Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks shake off global recovery worries

Fri, 09th Jul 2021 12:07

(Alliance News) - European stocks roared back on Friday from coronavirus-driven jitters in the previous session, with a weak UK GDP reading unable to stop the FTSE 100 advancing nearly 50 points by midday.

The FTSE 100 index was up 48.18 points, or 0.7%, at 7,078.84 midday Friday. The mid-cap FTSE 250 index was up 160.38 points, or 0.7%, at 22,813.10. The AIM All-Share index was 0.1% lower at 1,247.37.

The Cboe UK 100 index was up 0.7% at 704.55. The Cboe 250 was up 0.6% at 20,495.72, and the Cboe Small Companies up 0.2% at 15,418.98.

Stocks were rebounding at the end of a difficult week after worries over the global economic rebound in the face of the more infectious Delta coronavirus variant pounded markets on Thursday.

"Concerns over slowing global economic growth, rising Delta cases and the Fed moving towards tightening monetary policy proved too much for the markets to swallow," said Sophie Griffiths, market analyst at Oanda.

"Key technical levels were tested but not meaningfully breached," she said. "As a result, dip buyers are back in today, picking up bargains."

In mainland Europe early Friday afternoon, the CAC 40 in Paris surged 1.7% amid broad-based gains throughout the index while the DAX 30 in Frankfurt gained 0.8%.

Wall Street is also on course for a bright Friday, with the Dow Jones called up 0.4% and the S&P 500 up 0.2% but the Nasdaq Composite pointed down 0.3%

"Big tech could be under the spotlight as finance ministers and central bankers from the 20 largest economies meet in Vienna. Corporate tax reform will be at the top of the agenda, as the group looks to build on the momentum created at the G7 meeting," the Oanda analyst said.

London stocks were managing to shake off fears over economic growth peaking even after a weaker-than-expected UK gross domestic product reading.

UK GDP grew 0.8% in May from April, missing forecasts for a stronger monthly gain of 1.7%, according to FXStreet, and below April's growth of 2.0%, which itself was revised down from 2.3%. The economy remains 3.1% below its pre-virus levels, the ONS said.

ING remained upbeat despite the disappointing May figure.

"We'd still expect positive third-quarter growth of around 1.5%, especially given we're not currently looking at new restrictions – and indeed the government is planning a further relaxation on 19 July. And we'd still say the outlook beyond the summer looks reasonably good," said ING.

Sterling was trading at USD1.3801 at midday, up from USD1.3763 at the London equities close on Thursday.

The euro traded at USD1.1857 on Friday, rising from USD1.1842 late Thursday in London. Against the yen, the dollar rose to JPY109.91 versus JPY109.79.

Gold was quoted at USD1,804.29 an ounce midday Friday, higher than USD1,796.50 on Thursday. Brent oil was trading at USD74.70 a barrel, up from USD73.70 late Thursday.

Helping to support London's FTSE 100 index were ratings upgrades for Bunzl and Burberry. Bunzl was lifted to Buy from Hold at Berenberg, while Goldman Sachs upgraded trenchcoat maker Burberry to Buy from Neutral. Bunzl was up 2.8% at midday, while Burberry was up 3.0%.

Land Securities also was amongst the top performers, up 2.6%, after reporting "good progress" on rent collection.

As of Wednesday, the FTSE 100-listed property owner said that it has collected 81% of the GBP103 million net rent due by June 24. It also said it will pay a 7.0 pence per share dividend in October in its first quarterly payout for financial 2022.

At the bottom of London's blue-chip index was lockdown winner Just Eat Takeaway.com, falling 2.1% as jitters over the global economic recovery calmed.

Vectura shares surged 13% to 153.40 pence, topping the mid-cap FTSE 250 index, after agreeing to be taken over Marlboro cigarette maker Philip Morris International.

Philip Morris will pay 150p per share in cash for Vectura, a Wiltshire, England-based inhaled drug delivery devices maker. Including a 19p interim dividend, the deal values Vectura at GBP1.04 billion.

Following the PMI offer, Vectura's directors withdrew their recommendation for a GBP958 million takeover by funds managed by private equity firm Carlyle Group. PMI's offer is a 10% premium to Carlyle's 136p per share bid.

"PMI is expanding into products beyond tobacco and nicotine, as part of a natural evolution into a broader healthcare and wellness company," the New York-based company said.

Philip Morris shares were trading 0.6% higher pre-market in New York. The company is worth USD153.3 billion.

Elsewhere in London, MJ Gleeson rose 3.5% as it guided that annual results will top market expectations and match pre-virus levels.

The housebuilder said pretax profit for the financial year ended June 30 will be in line with two years earlier. MJ Gleeson posted pretax profit of GBP41.2 million in financial 2019, on revenue of GBP249.9 million. In financial 2020, revenue dropped 41% to GBP147.2 million, with pretax profit tumbling 86% to GBP5.6 million.

CEO James Thomson said: "I am pleased to announce that pretax profit is expected to be in line with that achieved in 2019, our last financial year before the impact of the pandemic."

To come in Friday's economic calendar are European Central Bank meeting minutes at 1230 BST and Canadian unemployment at 1330 BST.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.